<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6600">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01977703</url>
  </required_header>
  <id_info>
    <org_study_id>131336</org_study_id>
    <nct_id>NCT01977703</nct_id>
  </id_info>
  <brief_title>Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).</brief_title>
  <official_title>Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thoratec Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We propose to study a strategy empirically applied for the past 6 months at a high volume
      LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative
      device programming strategy to maximize battery longevity, avoid inappropriate implantable
      cardioverter defibrillator (ICD) therapy, improve quality of life through reduction in
      overall shock burden, and potentially avoid unnecessary device generator changes prior to
      transplant. Avoiding CIED (cardiac implantable electronic device) change out device
      procedures prior to transplant is desirable.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Time to first ICD shock following LVAD implant</measure>
    <time_frame>Within 12 months following LVAD implant</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of anti-tachycardia pacing (ATP) therapy administration for appropriate or inappropriate arrhythmia detection</measure>
    <time_frame>Within 12 months following LVAD implant</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of ATP occurrences</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of ICD generator change prior to definitive therapy</measure>
    <time_frame>Within 12 months following LVAD implant</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of patients requiring ICD generator change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac implantable electronic device (CIED) battery voltage/estimated longevity changes</measure>
    <time_frame>Within 12 months following LVAD implant</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Battery voltage and battery life measured in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of arrhythmic syncope</measure>
    <time_frame>Within 12 months following LVAD implant</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of syncope occurrences</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization frequency for decompensated congestive heart failure</measure>
    <time_frame>Within 12 months following LVAD implant</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of hospitalizations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine survival to heart transplantation following LVAD implant</measure>
    <time_frame>Within 12 months following LVAD implant</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of patients, post LVAD implant, to receive heart transplant and number of survival days post implant</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Traditional ICD Programming</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ICD will be set to pre-LVAD settings post LVAD implant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultra Conservative ICD Programming</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ICD will be set to ultra conservative settings post LVAD implant.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultra Conservative ICD Programming</intervention_name>
    <arm_group_label>Ultra Conservative ICD Programming</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Traditional ICD Programming</intervention_name>
    <arm_group_label>Traditional ICD Programming</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:

          -  Age â‰¥ 18

          -  Advanced Heart Failure

          -  Scheduled for Heartmate II LVAD implant

          -  With existing ICD

        Exclusion:

        -Age &lt; 18
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Ellis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christopher Ellis, MD</last_name>
    <phone>615-875-5500</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Beth Davis, MA</last_name>
      <phone>615-875-5500</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 6, 2013</lastchanged_date>
  <firstreceived_date>October 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Christopher Ellis</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Advanced Heart Failure</keyword>
  <keyword>LVAD</keyword>
  <keyword>Left Ventricular Assist Device</keyword>
  <keyword>Heart-Assist Devices</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
